European Healthtech startup funding raised during H1 2011.
In H1 2011, 40 European Healthtech companies raised a combined €307M across 41 funding rounds, up 48.4% versus H1 2010. Denmark led by capital raised, and Enterprise Ireland was the most active investor. Data as of 7 Aug 2026.
1 exit · €909M disclosed.
| BioVex | Acquisition | Jan 2011 | €909M |
| Mar 2011 |
| €14M |
| GenKyoTex | Series C | May 2011 | €14M |
| BONESUPPORT | Growth/Late | Jun 2011 | €13M |
| LifeBond | Series C | May 2011 | €13M |
| Sapiens | Series A | Jun 2011 | €13M |
| OrSense | Growth/Late | May 2011 | €12M |
| Nexstim | Other | Jan 2011 | €11M |
| InDex Pharmaceuticals | Other | Jan 2011 | €8.3M |
| Mendor | Series B | Jun 2011 | €8.1M |
| Impeto Medical | Other | Jan 2011 | €6.1M |
| Cappella Medical Devices | Series D+ | Feb 2011 | €5.2M |
| Craneware | Early VC | Jun 2011 | €4.2M |
